Cell MedX Corp. - FORM 10-Q - EX-32.1 - CERTIFICATION - April 14, 2016

Attached files

file filename
EX-31.2 - CERTIFICATION - Cell MedX Corp.ex312.htm
EX-32.2 - CERTIFICATION - Cell MedX Corp.ex322.htm
EX-31.1 - CERTIFICATION - Cell MedX Corp.ex311.htm
EX-10.35 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 10, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1035.htm
EX-10.36 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 30, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1036.htm
EX-10.37 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 31, 2016 AMONG CELL MEDX CORP., AND RICHARD N. JEFFS. - Cell MedX Corp.ex1037.htm
EX-10.30 - LOAN AGREEMENT AND NOTE PAYABLE DATED NOVEMBER 5, 2015, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1030.htm
EX-10.33 - LOAN AGREEMENT AND NOTE PAYABLE DATED MARCH 2, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1033.htm
10-Q - 10-Q - Cell MedX Corp.form10q.htm
EX-10.32 - LOAN AGREEMENT AND NOTE PAYABLE DATED FEBRUARY 4, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1032.htm


CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the Quarterly Report of Cell MedX Corp. (the “Company”) on Form 10-Q for the period ending February 29, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
 
 
(1)   The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Dated: April 14, 2016
 
/s/ Frank E. McEnulty
Frank E. McEnulty
Chief Executive Officer and President
(Principal Executive Officer)


 
 
 

Cell MedX Corp. Reports

Also read